Andrew Hwang
Associate Professor of Pharmacy Practice
About
Dr. Andrew Hwang received his Pharm.D. degree from the University of Florida College of Pharmacy. He completed a PGY-1 Pharmacy Residency at New Hanover Regional Medical Center. After his residency, Dr. Hwang completed a postdoctoral fellowship in Family Medicine Pharmacy at the University of Florida. In 2017, he became a faculty member at the Fred Wilson School of Pharmacy at High Point University. Andrew joined the faculty at MCPHS School of Pharmacy Boston in 2022. His clinical interests include cardiovascular health and cardiometabolic disorders.
Education
- Pharm.D., University of Florida; Gainesville, FL
- PGY-1 Pharmacy Practice, New Hanover Regional Medical Center; Wilmington, NC
- Family Medicine Pharmacy Fellowship, University of Florida; Gainesville, FL
- Board Certified Pharmacotherapy Specialist
Research Interests
- Pharmacoepidemiology
- Medication safety
- Health disparities
Featured Affiliations
American College of Clinical Pharmacy (ACCP)
WebsiteAmerican Heart Association (AHA)
WebsiteAmerican Association of Colleges of Pharmacy (AACP)
WebsiteEducation
- Pharm.D., University of Florida; Gainesville, FL
- PGY-1 Pharmacy Practice, New Hanover Regional Medical Center; Wilmington, NC
- Family Medicine Pharmacy Fellowship, University of Florida; Gainesville, FL
- Board Certified Pharmacotherapy Specialist
Research Interests
- Pharmacoepidemiology
- Medication safety
- Health disparities
Publications
- Wasserman RL, Seger DL, Amato MG, Hwang AY, Fiskio J, Bates DW. A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Saf. 2024;47(12):1235-1243.
- Wasserman RL, Edrees HH, Amato MG, Seger DL, Frits ML, Hwang AY, Iannaccone C, Bates DW. Frequency and preventability of adverse drug events in the outpatient setting. BMJ Qual Saf. 2024; Jul 9:bmjqs-2024-017098. doi: 10.1136/bmjqs-2024-017098.
- Bickenbach EM, Keegan CL, Brockel MC, Mast OG, Ghantae A, Hwang AY, Sherrill CH. Changes in Metabolic Parameters of Hemoglobin A1c, Weight, and Blood Pressure During and After COVID-19 Stay-at-Home Orders. J Am Board Fam Med. 2024; jabfm.2023.230205R1.
- Bou-Ghazale L, Oldham E, Bundeff AW, Hwang AY. Evaluation of the change in glycated hemoglobin for patients in an employee health program formerly managed by a pharmacist-run ambulatory care clinic. Am J Health Syst Pharm. 2023;80(21):1564-1569.
- Hayes M, Lynch A, Yoder V, Hwang A, Alderman L, Adewodu T, Baker D. Implementation of pharmacist recommendations in patients with type 2 diabetes enrolled in an employer-sponsored health plan. J Am Pharm Assoc (2003). 2023; 63(4S):S73-S77.
- Sherrill CH, Hwang AY. Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020. Ann Pharmacother. 2023; Jun 15:10600280231178886.
- Zhou J, Sherrill CH, Hwang AY, Lee S. Association between mental health and self-care behavior among older adults with diabetes according to Behavioral Risk Factor Surveillance System 2019. Prim Care Diabetes. 2023;S1751-9918(23)00036-0. doi: 10.1016/j.pcd.2023.02.005.
- Bradley CL, McMillin SM, Hwang AY, Sherrill CH. Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. Ann Pharmacother. 2022; doi:10.1177/10600280221134127.
- Bradley CL, McMillin SM, Hwang AY, Sherrill CH. High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management. Ann Pharmacother. 2022;56(8):941-950.
- Hwang AY, Cardel MI, Smith SM. Racial and ethnic differences in blood pressure before and after the 2016 United States general election. Am J Hum Biol 2022;e23785; https://doi.org/10.1002/ajhb.23785.
- Helms MV, Edwards AL, Suszynsky TH, Hwang AY. Prescribing Patterns of Antihypertensive Agents and Blood Pressure Control Among Patients with Incident Stage 2 Hypertension. J Pharm Technol 2022;38(3):142-147.
- Hwang AY, Smith SM. U.S. Trends in Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients with Cardiovascular Disease, 1988-2016. Pharmacotherapy 2021;41:247-256.
- Hwang AY, Dave CV, Smith SM. Use of Prescription Medications that Potentially Interfere with Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension. Am J Hypertens 2018;31(12):1324-1331.
- Hwang AY, Carris NW, Dietrich EA, Gums JG, Smith SM. Evaluation of SAMe-TT2R2 Score on Predicting Success With Extended-Interval Warfarin Monitoring. Ann Pharmacother 2018;52(11):1085-1090.
- Hwang AY, Gums TH, Gums JG. The benefits of physician-pharmacist collaboration. J Fam Pract. 2017;66(12):E1-E8.
- Hwang AY, Dietrich E, Pepine CJ, Smith SM. Resistant Hypertension: Mechanisms and Treatment. Curr Hypertens Rep. 2017;19(7):56. doi: 10.1007/s11906-017-0754-x.
- Hwang AY, Dave CV, Smith SM. Trends in Antihypertensive Medication Use Among US Patients with Resistant Hypertension, 2008 to 2014. Hypertension 2016;68:1349-1354.
- Conway SE, Hwang AY, Ponte CD, Gums JG. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know. Pharmacotherapy 2017;37(2):236-248.
- Carris NW, Hwang AY, Smith SM, Taylor JR, Sando K, Powell J, Rosenberg EI, Zumberg MS, Gums JG, Dietrich EA, Vogel Anderson K. Anticoagulation-related satisfaction associated with extended-interval warfarin monitoring: A pre-specified analysis of the FADE-OUT study. J Thromb Thrombolysis 2016;42(4):486-493.
- Hwang AY, Gums JG. The emergence and evolution of antimicrobial resistance: Impact on a global scale. Bioorg Med Chem 2016;24(4):6440-6445.